Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing

Since September 2010, over 10,000 patients have undergone preemptive, panel-based pharmacogenomic testing through the Vanderbilt Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment (PREDICT) program. Analysis of the genetic data from the first 9,589 individuals reveals the frequenc...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Van Driest, Sara L., Shi, Yaping, Bowton, Erica A., Schildcrout, Jonathan S., Peterson, Josh F., Pulley, Jill, Denny, Josh C., Roden, Dan M.
Формат: Artigo
Язык:Inglês
Опубликовано: 2013
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3961508/
https://ncbi.nlm.nih.gov/pubmed/24253661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2013.229
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы